Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Evripidis Gavathiotis
Affiliation
Albert Einstein College of Medicine
ORCID
Career Start Year
2000
Papers
59
H Index
36
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36496299
Mitochondrial dynamics proteins as emerging drug targets.
Trends Pharmacol Sci
2023
38051103
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors.
Cancer Res Commun
2023
37821702
Apoptotic stress causes mtDNA release during senescence and drives the SASP.
Nature
2023
37100955
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Cell Death Differ
2023
36383673
Chaperone-mediated autophagy regulates adipocyte differentiation.
Sci Adv
2022
35864098
Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degeneration.
Nat Commun
2022
33442062
Chaperone-mediated autophagy sustains haematopoietic stem-cell function.
Nature
2021
33602934
Eltrombopag directly inhibits BAX and prevents cell death.
Nat Commun
2021
33891876
Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome.
Cell
2021
34110247
Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis.
Autophagy
2021
32421206
In Response to Regarding: Apoptosis Signaling Molecules as Treatment Targets in Head and Neck Squamous Carcinoma.
Laryngoscope
2020
31894587
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Laryngoscope
2020
31048321
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
Cancer Discov
2019
29677443
ICBS 2017 in Shanghai-Illuminating Life with Chemical Innovation.
ACS Chem Biol
2018
29674596
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.
Science
2018
29362479
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
Cell Death Differ
2018
29492188
Pulling the BAX trigger for tumor cell death.
Oncotarget
2018
29461827
Current Insights of BRAF Inhibitors in Cancer.
J Med Chem
2018
28735187
Progress in targeting the BCL-2 family of proteins.
Curr Opin Chem Biol
2017
28465352
Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A.
J Biol Chem
2017
29083320
Pharmacological inhibition of the transcription factor PU.1 in leukemia.
J Clin Invest
2017
28984291
New perspectives for targeting RAF kinase in human cancer.
Nat Rev Cancer
2017
29017059
Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia.
Cancer Cell
2017
28801102
Editorial overview: Chemical genetics and epigenetics.
Curr Opin Chem Biol
2017
26799652
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy
2016
26565029
Synthetic Antibodies Inhibit Bcl-2-associated X Protein (BAX) through Blockade of the N-terminal Activation Site.
J Biol Chem
2016
27768876
An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway.
Mol Cell
2016
27702998
Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation: DRUGGABILITY OF THE SMALL GTPase Rab27a.
J Biol Chem
2016
27626173
Self-regulation of BAX-induced cell death.
Oncotarget
2016
27775718
Correcting mitochondrial fusion by manipulating mitofusin conformations.
Nature
2016
27622340
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.
Cancer Cell
2016
27425408
An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway.
Mol Cell
2016
27523909
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.
Cancer Cell
2016
27315536
Chemical genetics: Unraveling cell death mysteries.
Nat Chem Biol
2016
25437618
Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
Eur J Med Chem
2015
26344567
An interconnected hierarchical model of cell death regulation by the BCL-2 family.
Nat Cell Biol
2015
25684204
Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism.
Mol Cell
2015
24358963
Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies.
ACS Chem Biol
2014
25049413
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.
Proc Natl Acad Sci U S A
2014
25076060
Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim.
Mar Drugs
2014
23584676
Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives.
Nat Chem Biol
2013
23890007
Multimodal interaction with BCL-2 family proteins underlies the proapoptotic activity of PUMA BH3.
Chem Biol
2013
22622039
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.
J Clin Invest
2012
22999885
A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival.
Chem Biol
2012
22493254
Bax regulates primary necrosis through mitochondrial dynamics.
Proc Natl Acad Sci U S A
2012
22634637
Direct and selective small-molecule activation of proapoptotic BAX.
Nat Chem Biol
2012
21325897
Tracking BAX once its trigger is pulled.
Cell Cycle
2011
21978892
BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore.
Trends Biochem Sci
2011
20660316
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.
Proc Natl Acad Sci U S A
2010
21070973
BH3-triggered structural reorganization drives the activation of proapoptotic BAX.
Mol Cell
2010
1 - 50 of 59
Column Actions
Search
Recommended Authors
Evangelos Pazarentzos
University of California san francisco
Career Start Year
2011
Number of shared co-authors
1
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year
2011
Number of shared co-authors
0
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year
2007
Number of shared co-authors
1
Isabelle Martins
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Career Start Year
2007
Number of shared co-authors
2
James R Whittle
Walter and Eliza Hall Institute of Medical Research
Career Start Year
2006
Number of shared co-authors
0
Kris C Wood
Duke University
Career Start Year
2005
Number of shared co-authors
4
Lisa M Miller Jenkins
National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
1
Jianwei Che
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
3
Malia B Potts
St. Jude Children's Research Hospital
Career Start Year
2004
Number of shared co-authors
1
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year
2003
Number of shared co-authors
1
Almer M van der Sloot
Institute for Research in Immunology and Cancer, Universite de Montreal
Career Start Year
2003
Number of shared co-authors
1
William H Bisson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2001
Number of shared co-authors
1
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Career Start Year
2001
Number of shared co-authors
6
Nancy Su
Career Start Year
2000
Number of shared co-authors
0
Rima Al-Awar
Ontario Institute for Cancer Research, University Avenue
Career Start Year
1999
Number of shared co-authors
1
Chandra C Ghosh
The Wistar Institute
Career Start Year
1999
Number of shared co-authors
1
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year
1999
Number of shared co-authors
0
Kenneth D Westover
University of Texas Southwestern Medical Center
Career Start Year
1998
Number of shared co-authors
3
Michael C Bassik
Stanford University Medical Center
Career Start Year
1997
Number of shared co-authors
5
Ranjini K Sundaram
Yale University
Career Start Year
1996
Number of shared co-authors
0
Jack Taunton
University of California san francisco
Career Start Year
1996
Number of shared co-authors
3
Krister Wennerberg
University of Copenhagen
Career Start Year
1994
Number of shared co-authors
0
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
2
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year
1992
Number of shared co-authors
2
Ricky W Johnstone
The University of Melbourne
Career Start Year
1990
Number of shared co-authors
0
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year
1989
Number of shared co-authors
2
Stuart L Schreiber
Broad Institute
Career Start Year
1985
Number of shared co-authors
7
Stefan Knapp
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year
1983
Number of shared co-authors
7
David W Andrews
Sunnybrook Research Institute, University of Toronto
Career Start Year
1978
Number of shared co-authors
8
row(s) 1 - 30 of 30
Collaborators
Ana Maria Cuervo
Albert Einstein College of Medicine
Co-authored papers
8
Richard N Kitsis
Co-authored papers
5
Qisheng Xin
Albert Einstein College of Medicine
Co-authored papers
5
Gerald W Dorn
Co-authored papers
4
Susmita Kaushik
Albert Einstein College of Medicine
Co-authored papers
4
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers
3
Ted M Dawson
Johns Hopkins University School of Medicine
Co-authored papers
3
Antonio Diaz
Albert Einstein College of Medicine, USA Institute for Aging Studies
Co-authored papers
3
Brent R Stockwell
Columbia University
Co-authored papers
3
Inmaculada Tasset
Albert Einstein College of Medicine
Co-authored papers
3
Valina L Dawson
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers
3
Jan Paul Medema
Oncode Institute
Co-authored papers
3
Stuart A Lipton
The Scripps Research Institute, University of California
Co-authored papers
2
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Co-authored papers
2
Michael Karin
Co-authored papers
2
Yves R Juste
Albert Einstein College of Medicine
Co-authored papers
2
Milton H Werner
Inhibikase Therapeutics Inc.
Co-authored papers
2
Jerry E Chipuk
Co-authored papers
2
Rosario Rizzuto
Co-authored papers
2
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
2
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers
2
Simone Fulda
Co-authored papers
2
Brian D Dynlacht
New York University Cancer Institute, New York University School of Medicine
Co-authored papers
2
Nicola Di Daniele
University of Rome Tor Vergata
Co-authored papers
2
Laura Santambrogio
Weill Cornell School of Medicine
Co-authored papers
2
Vladimir N Malashkevich
Albert Einstein College of Medicine
Co-authored papers
2
David Sulzer
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers
2
Ian G Mills
Queen's University Belfast
Co-authored papers
1
Il??ana Antony-Debr??
INSERM, France Villejuif Universite Paris-Saclay
Co-authored papers
1
Hirotaka Watada
Co-authored papers
1
1 - 30